Teva Pharma Industries Ltd ADR (NYSE: TEVA) is the world's largest generic drug maker, with over 500 generic and biosimilar treatments in its broad portfolio. The medical sector giant also has a line ...

New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment LONDON, Feb. 4, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading ...

A study from the University of Birmingham, UK, has indicated that the use of digoxin could lead to substantial cost savings ...

First used in 1785, this century-old medication is now emerging as a modern solution with significant healthcare benefits ...

Using a most cost-effective drug to treat some of the most common and dangerous heart conditions could save the NHS a ...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating ...

Flossing regularly may lower the risk of some strokes as well as a type of irregular heart rhythm that can increase stroke risk, new research suggests.

Doylestown Health is broadening its treatment options for atrial fibrillation patients with a revolutionary system that ...